Simulations Plus, Inc. (SLP) 10-Year Financial Performance & Capital Metrics

SLP • • Industrial / General

HealthcareHealthcare ITLife Sciences TechnologyDrug Discovery & Development

AboutSimulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.Show more

Revenue $79M +13.1%
EBITDA -$63M -630.0%
Net Income -$65M -750.2%
EPS (Diluted) -3.22 -757.1%
Gross Margin 58.38% -5.3%
EBITDA Margin -78.96% -568.6%
Operating Margin -89.33% -1120.1%
Net Margin -81.74% -674.9%
ROE -42.13% -845.9%
ROIC -39.63% -1336.1%
Debt/Equity 0.00 -10.5%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓FCF machine: 22.0% free cash flow margin
✓Strong 5Y sales CAGR of 13.7%

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y15.77%

5Y13.74%

3Y13.67%

TTM5.69%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-882.08%

EPS CAGR

10Y-

5Y-

3Y-

TTM-895.72%

ROCE

10Y Avg9.99%

5Y Avg-4.17%

3Y Avg-12.01%

Latest-44.1%

Peer Comparison

Drug Discovery & Development

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SLPSimulations Plus, Inc.	408.17M	20.26	-6.29	13.09%	-81.66%	-50.54%	4.27%	0.00
SDGRSchrödinger, Inc.	1.13B	17.47	-6.80	-4.21%	-68.49%	-54.77%		0.28
CERTCertara, Inc.	1.52B	9.52	-126.76	8.7%	2.62%	1.02%	5.2%	0.29

Profit & Loss

	Aug 2016	Aug 2017	Aug 2018	Aug 2019	Aug 2020	Aug 2021	Aug 2022	Aug 2023	Aug 2024	Aug 2025
Sales/Revenue+	19.97M	24.14M	29.67M	33.97M	41.59M	46.47M	53.91M	59.58M	70.01M	79.18M
Revenue Growth %	0.09%	0.21%	0.23%	0.15%	0.22%	0.12%	0.16%	0.11%	0.18%	0.13%
Cost of Goods Sold+	4.6M	6.31M	7.99M	9.03M	10.65M	10.6M	10.82M	11.63M	26.86M	32.96M
COGS % of Revenue	0.23%	0.26%	0.27%	0.27%	0.26%	0.23%	0.2%	0.2%	0.38%	0.42%
Gross Profit+	15.37M	17.83M	21.67M	24.94M	30.94M	35.87M	43.08M	47.95M	43.15M	46.22M
Gross Margin %	0.77%	0.74%	0.73%	0.73%	0.74%	0.77%	0.8%	0.8%	0.62%	0.58%
Gross Profit Growth %	0.1%	0.16%	0.22%	0.15%	0.24%	0.16%	0.2%	0.11%	-0.1%	0.07%
Operating Expenses+	8.14M	9.57M	11.37M	14.3M	19.34M	24.61M	28.17M	39.22M	37.02M	116.95M
OpEx % of Revenue	0.41%	0.4%	0.38%	0.42%	0.46%	0.53%	0.52%	0.66%	0.53%	1.48%
Selling, General & Admin	6.69M	8.2M	9.58M	11.8M	16.36M	20.57M	24.96M	34.72M	31.27M	32.84M
SG&A % of Revenue	0.34%	0.34%	0.32%	0.35%	0.39%	0.44%	0.46%	0.58%	0.45%	0.41%
Research & Development	1.45M	1.37M	1.79M	2.5M	2.98M	4.05M	3.21M	4.5M	5.75M	6.88M
R&D % of Revenue	0.07%	0.06%	0.06%	0.07%	0.07%	0.09%	0.06%	0.08%	0.08%	0.09%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	77.22M
Operating Income+	7.23M	8.26M	10.3M	10.65M	11.61M	11.25M	14.91M	8.72M	6.13M	-70.73M
Operating Margin %	0.36%	0.34%	0.35%	0.31%	0.28%	0.24%	0.28%	0.15%	0.09%	-0.89%
Operating Income Growth %	0.23%	0.14%	0.25%	0.03%	0.09%	-0.03%	0.33%	-0.41%	-0.3%	-12.54%
EBITDA+	9.16M	10.4M	13.02M	13.4M	14.57M	14.84M	18.48M	12.56M	11.8M	-62.52M
EBITDA Margin %	0.46%	0.43%	0.44%	0.39%	0.35%	0.32%	0.34%	0.21%	0.17%	-0.79%
EBITDA Growth %	0.17%	0.13%	0.25%	0.03%	0.09%	0.02%	0.25%	-0.32%	-0.06%	-6.3%
D&A (Non-Cash Add-back)	1.93M	2.14M	2.72M	2.75M	2.96M	3.59M	3.57M	3.84M	5.67M	8.21M
EBIT	7.24M	8.28M	10.3M	10.56M	11.39M	11.11M	15.12M	9.22M	6.13M	6.49M
Net Interest Income+	18.01K	-22.33K	27.12K	34K	30K	179K	717K	4.13M	4.38M	722K
Interest Income	18.01K	15.86K	27.12K	34K	30K	201K	717K	4.13M	4.38M	722K
Interest Expense	0	38.19K	0	0	0	22K	0	0	0	0
Other Income/Expense	4.59K	-24.02K	-158.85K	-92K	-218K	-168K	204K	2.97M	6.28M	1.35M
Pretax Income+	7.24M	8.24M	10.14M	10.56M	11.39M	11.09M	15.12M	11.7M	12.41M	-69.38M
Pretax Margin %	0.36%	0.34%	0.34%	0.31%	0.27%	0.24%	0.28%	0.2%	0.18%	-0.88%
Income Tax+	2.29M	2.45M	1.2M	1.97M	2.06M	1.3M	2.63M	1.73M	2.46M	-4.66M
Effective Tax Rate %	0.68%	0.7%	0.88%	0.81%	0.82%	0.88%	0.83%	0.85%	0.8%	0.93%
Net Income+	4.95M	5.79M	8.93M	8.58M	9.33M	9.78M	12.48M	9.96M	9.95M	-64.72M
Net Margin %	0.25%	0.24%	0.3%	0.25%	0.22%	0.21%	0.23%	0.17%	0.14%	-0.82%
Net Income Growth %	0.29%	0.17%	0.54%	-0.04%	0.09%	0.05%	0.28%	-0.2%	-0%	-7.5%
Net Income (Continuing)	4.95M	5.79M	8.93M	8.58M	9.33M	9.78M	12.48M	9.96M	9.95M	-64.72M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	0.29	0.33	0.50	0.48	0.50	0.47	0.60	0.49	0.49	-3.22
EPS Growth %	0.26%	0.14%	0.52%	-0.04%	0.04%	-0.06%	0.28%	-0.18%	0%	-7.57%
EPS (Basic)	0.29	0.34	0.52	0.49	0.52	0.49	0.62	0.50	0.50	-3.22
Diluted Shares Outstanding	17.21M	17.52M	17.86M	18.06M	18.54M	20.74M	20.75M	20.46M	20.3M	20.1M
Basic Shares Outstanding	17.03M	17.24M	17.33M	17.49M	17.82M	20.05M	20.2M	20.07M	19.99M	20.1M
Dividend Payout Ratio	0.69%	0.6%	0.47%	0.49%	0.46%	0.49%	0.39%	0.48%	0.48%	-

Balance Sheet

	Aug 2016	Aug 2017	Aug 2018	Aug 2019	Aug 2020	Aug 2021	Aug 2022	Aug 2023	Aug 2024	Aug 2025
Total Current Assets+	12.93M	12.67M	17.82M	21.17M	129.09M	139.31M	146.79M	130.37M	39.34M	51.55M
Cash & Short-Term Investments	8.03M	6.22M	9.4M	11.44M	116.01M	123.6M	128.24M	115.46M	20.25M	32.35M
Cash Only	8.03M	6.22M	9.4M	11.44M	49.21M	36.98M	51.57M	57.52M	10.31M	30.85M
Short-Term Investments	0	0	0	0	66.8M	86.62M	76.67M	57.94M	9.94M	1.5M
Accounts Receivable	3.7M	5.53M	7.5M	8.26M	10.52M	13.05M	13.79M	10.2M	9.14M	14.62M
Days Sales Outstanding	67.69	83.62	92.28	88.75	92.28	102.52	93.35	62.5	47.63	67.38
Inventory	784.2K	462.44K	312.59K	765.11K	969.69K	1.01M	1.39M	804K	0	0
Days Inventory Outstanding	62.2	26.76	14.27	30.94	33.24	34.85	46.92	25.23	-	-
Other Current Assets	410.81K	459.9K	610.44K	704.32K	1.6M	1.65M	3.38M	3.9M	7.75M	2.8M
Total Non-Current Assets+	15.11M	25.84M	26.33M	24.93M	40.73M	42.3M	43.71M	62.27M	168.3M	80.39M
Property, Plant & Equipment	256.38K	291.13K	335.22K	341.14K	1.36M	3.11M	2.05M	1.92M	1.84M	1.29M
Fixed Asset Turnover	77.90x	82.91x	88.50x	99.58x	30.48x	14.92x	26.27x	31.06x	38.07x	61.52x
Goodwill	4.79M	10.39M	10.39M	10.39M	12.92M	12.92M	12.92M	19.1M	96.08M	43.72M
Intangible Assets	10.03M	15.13M	14.7M	13.27M	24.99M	24.58M	26.18M	32.85M	58.84M	29.21M
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	34.08K	34.08K	37.23K	37.23K	50.97K	51K	439K	425K	542K	1.4M
Total Assets+	27.81M	38.51M	44.15M	46.09M	169.82M	181.61M	190.5M	192.64M	207.64M	131.94M
Asset Turnover	0.72x	0.63x	0.67x	0.74x	0.24x	0.26x	0.28x	0.31x	0.34x	0.60x
Asset Growth %	0.02%	0.38%	0.15%	0.04%	2.68%	0.07%	0.05%	0.01%	0.08%	-0.36%
Total Current Liabilities+	2.13M	2.04M	4.83M	4.78M	5.5M	11.57M	7.74M	11.99M	12.07M	6.72M
Accounts Payable	108.11K	240.89K	351.61K	204.07K	351K	387K	225K	144K	602K	470K
Days Payables Outstanding	8.58	13.94	16.05	8.25	12.03	13.33	7.59	4.52	8.18	5.21
Short-Term Debt	0	0	0	0	463.46K	382K	461K	442K	475K	206K
Deferred Revenue (Current)	406.52K	570.92K	766.53K	1000K	440.47K	651K	1000K	1000K	1000K	1000K
Other Current Liabilities	1.01M	1.23M	3.71M	3.4M	4.25M	10.15M	931K	3.91M	4.48M	1.34M
Current Ratio	6.08x	6.20x	3.69x	4.42x	23.45x	12.04x	18.98x	10.88x	3.26x	7.67x
Quick Ratio	5.71x	5.98x	3.63x	4.26x	23.28x	11.95x	18.80x	10.81x	3.26x	7.67x
Cash Conversion Cycle	121.31	96.44	90.5	111.44	113.49	124.04	132.68	83.21	-	-
Total Non-Current Liabilities+	2.96M	10.67M	7.4M	3.63M	8.28M	4.26M	4.52M	10.62M	13.14M	410K
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	463.31K	896K	943K	755K	531K	410K
Deferred Tax Liabilities	2.96M	4.93M	4.07M	3.63M	3.75M	3.36M	3.58M	6.54M	12.61M	0
Other Non-Current Liabilities	0	5.74M	3.33M	0	4.06M	0	0	3.33M	0	0
Total Liabilities	5.08M	12.71M	12.23M	8.41M	13.78M	15.83M	12.26M	22.61M	25.21M	7.13M
Total Debt+	0	0	0	0	926.78K	1.28M	1.4M	1.2M	1.01M	616K
Net Debt	-8.03M	-6.22M	-9.4M	-11.44M	-48.28M	-35.71M	-50.16M	-56.33M	-9.3M	-30.24M
Debt / Equity	-	-	-	-	0.01x	0.01x	0.01x	0.01x	0.01x	0.00x
Debt / EBITDA	-	-	-	-	0.06x	0.09x	0.08x	0.10x	0.09x	-
Net Debt / EBITDA	-0.88x	-0.60x	-0.72x	-0.85x	-3.31x	-2.41x	-2.71x	-4.48x	-0.79x	-
Interest Coverage	-	216.41x	-	-	-	511.50x	-	-	-	-
Total Equity+	22.73M	25.8M	31.92M	37.68M	156.04M	165.78M	178.25M	170.03M	182.43M	124.8M
Equity Growth %	0.16%	0.14%	0.24%	0.18%	3.14%	0.06%	0.08%	-0.05%	0.07%	-0.32%
Book Value per Share	1.32	1.47	1.79	2.09	8.42	7.99	8.59	8.31	8.99	6.21
Total Shareholders' Equity	22.73M	25.8M	31.92M	37.68M	156.04M	165.78M	178.25M	170.03M	182.43M	124.8M
Common Stock	7.23K	7.28K	7.42K	7.59K	9.93K	133.42M	138.51M	144.97M	20K	20K
Retained Earnings	11.35M	13.69M	18.46M	22.35M	27.44M	32.41M	40.04M	25.2M	30.35M	-34.36M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	58.47K	-43K	-308K	-141K	-251K	-271K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Aug 2016	Aug 2017	Aug 2018	Aug 2019	Aug 2020	Aug 2021	Aug 2022	Aug 2023	Aug 2024	Aug 2025
Cash from Operations+	5.42M	6.88M	9.29M	11.64M	10.91M	19.2M	17.9M	21.86M	13.32M	18.13M
Operating CF Margin %	0.27%	0.28%	0.31%	0.34%	0.26%	0.41%	0.33%	0.37%	0.19%	0.23%
Operating CF Growth %	-0.24%	0.27%	0.35%	0.25%	-0.06%	0.76%	-0.07%	0.22%	-0.39%	0.36%
Net Income	4.95M	5.79M	8.93M	8.58M	9.33M	9.78M	12.48M	9.96M	9.95M	-64.72M
Depreciation & Amortization	1.93M	2.14M	2.72M	2.75M	2.96M	3.59M	3.57M	3.84M	5.67M	8.21M
Stock-Based Compensation	347.08K	585.02K	709.08K	1.08M	1.58M	2.75M	3.04M	4.83M	6.54M	6.35M
Deferred Taxes	-23.24K	-178.37K	-1.73M	-299.1K	-377.76K	-628K	-270K	-2.1M	-1.76M	-5.43M
Other Non-Cash Items	5.63M	74.95K	152.75K	109.06K	202.03K	2.73M	1.7M	219K	-2.86M	76.29M
Working Capital Changes	-1.79M	-1.53M	-1.5M	-582.96K	-2.78M	974K	-2.62M	5.1M	-4.21M	-2.59M
Change in Receivables	-1.42M	-876.23K	-1.47M	487.97K	-2.02M	-2.43M	-3.94M	4.1M	3.13M	-581K
Change in Inventory	-495.02K	-378.99K	-339.46K	-1.31M	-247.25K	3.15M	0	0	0	0
Change in Payables	-101.3K	99.34K	110.71K	-147.53K	220.58K	39K	-162K	-81K	-477K	-132K
Cash from Investing+	-1.95M	-4.36M	-2.33M	-1.96M	-75.51M	-26.74M	4.3M	7.37M	-53.97M	3.56M
Capital Expenditures	-1.23M	-1.56M	-2.33M	-1.96M	-2.58M	-4.58M	-3.97M	-4.27M	-566K	-713K
CapEx % of Revenue	0.06%	0.06%	0.08%	0.06%	0.06%	0.1%	0.07%	0.07%	0.01%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-1.2M	-1.38M	-2.15M	0	-2.35M	-2.95M	-3.15M	0	-3.73M	-4.24M
Cash from Financing+	-3.98M	-4.34M	-3.77M	-7.65M	102.37M	-4.68M	-7.62M	-23.27M	-6.57M	-1.15M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-3.41M	-3.45M	-4.16M	-4.2M	-4.25M	-4.81M	-4.85M	-4.81M	-4.8M	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-567.95K	-888.6K	388.25K	-3.45M	-1.13M	-1.33M	-3.67M	1.54M	-2.5M	-1.58M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	4.18M	5.32M	6.96M	9.68M	8.33M	14.63M	13.93M	17.58M	12.75M	17.41M
FCF Margin %	0.21%	0.22%	0.23%	0.29%	0.2%	0.31%	0.26%	0.3%	0.18%	0.22%
FCF Growth %	-0.29%	0.27%	0.31%	0.39%	-0.14%	0.76%	-0.05%	0.26%	-0.27%	0.37%
FCF per Share	0.24	0.30	0.39	0.54	0.45	0.71	0.67	0.86	0.63	0.87
FCF Conversion (FCF/Net Income)	1.09x	1.19x	1.04x	1.36x	1.17x	1.96x	1.43x	2.19x	1.34x	-0.28x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	2.91M	2.69M	2.71M	2.67M	2.35M	1.86M	3.23M	3.2M	5.69M	1.16M

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	23.42%	23.85%	30.96%	24.66%	9.63%	6.08%	7.26%	5.72%	5.65%	-42.13%
Return on Invested Capital (ROIC)	42.24%	36.15%	36.68%	32.75%	12.99%	7.1%	8.66%	5.41%	3.21%	-39.63%
Gross Margin	76.96%	73.87%	73.05%	73.43%	74.39%	77.19%	79.92%	80.48%	61.63%	58.38%
Net Margin	24.79%	23.98%	30.12%	25.27%	22.44%	21.05%	23.16%	16.72%	14.22%	-81.74%
Debt / Equity	-	-	-	-	0.01x	0.01x	0.01x	0.01x	0.01x	0.00x
Interest Coverage	-	216.41x	-	-	-	511.50x	-	-	-	-
FCF Conversion	1.09x	1.19x	1.04x	1.36x	1.17x	1.96x	1.43x	2.19x	1.34x	-0.28x
Revenue Growth	9.05%	20.86%	22.9%	14.51%	22.43%	11.73%	16.01%	10.52%	17.52%	13.09%

Revenue by Segment

	2014	2018	2019	2020	2021	2022	2023	2024	2025
License and Maintenance	-	-	-	-	-	-	-	41.02M	45.83M
License and Maintenance Growth	-	-	-	-	-	-	-	-	11.71%
Service	-	-	-	-	18.8M	-	-	28.99M	33.35M
Service Growth	-	-	-	-	-	-	-	-	15.05%
Software	-	-	-	-	27.67M	32.64M	36.52M	-	-
Software Growth	-	-	-	-	-	17.97%	11.87%	-	-
Services	-	-	-	-	-	21.26M	23.06M	-	-
Services Growth	-	-	-	-	-	-	8.45%	-	-
Operatings	-	-	-	41.59M	-	-	-	-	-
Operatings Growth	-	-	-	-	-	-	-	-	-
Simulations Plus, Inc.	-	30K	54K	21.96M	-	-	-	-	-
Simulations Plus, Inc. Growth	-	-	80.00%	40568.52%	-	-	-	-	-
Cognigen	-	-	-	11.11M	-	-	-	-	-
Cognigen Growth	-	-	-	-	-	-	-	-	-
D I L Isym	-	-	-	6.95M	-	-	-	-	-
D I L Isym Growth	-	-	-	-	-	-	-	-	-
Lixoft	-	-	-	1.57M	-	-	-	-	-
Lixoft Growth	-	-	-	-	-	-	-	-	-
DILIsym	-	3.16M	-	-	-	-	-	-	-
DILIsym Growth	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2014	2018	2019	2020	2021	2022	2023	2024	2025
North And South America	-	-	-	29.67M	32.55M	37.68M	40.82M	50.47M	57.7M
North And South America Growth	-	-	-	-	9.69%	15.77%	8.32%	23.66%	14.32%
Europe	2.98M	-	-	-	-	-	-	-	14.19M
Europe Growth	-	-	-	-	-	-	-	-	-
Asia	2.82M	-	-	6.09M	6.01M	5.84M	7.05M	5.47M	7.29M
Asia Growth	-	-	-	-	-1.26%	-2.89%	20.73%	-22.41%	33.25%
EMEA	-	-	-	5.83M	7.91M	10.39M	11.71M	14.07M	-
EMEA Growth	-	-	-	-	35.68%	31.39%	12.76%	20.14%	-
North America	5.63M	-	-	-	-	-	-	-	-
North America Growth	-	-	-	-	-	-	-	-	-
South America	26K	-	-	-	-	-	-	-	-
South America Growth	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Simulations Plus, Inc. (SLP) reported $78.7M in revenue for fiscal year 2025. This represents a 733% increase from $9.4M in 2012.

Simulations Plus, Inc. (SLP) grew revenue by 13.1% over the past year. This is steady growth.

Simulations Plus, Inc. (SLP) reported a net loss of $64.2M for fiscal year 2025.

Dividend & Returns

Simulations Plus, Inc. (SLP) has a return on equity (ROE) of -42.1%. Negative ROE indicates the company is unprofitable.

Simulations Plus, Inc. (SLP) generated $23.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Simulations Plus, Inc. (SLP) 10-Year Financial Performance & Capital Metrics

SLP • • Industrial / General

HealthcareHealthcare ITLife Sciences TechnologyDrug Discovery & Development

Revenue $79M +13.1%
EBITDA -$63M -630.0%
Net Income -$65M -750.2%
EPS (Diluted) -3.22 -757.1%
Gross Margin 58.38% -5.3%
EBITDA Margin -78.96% -568.6%
Operating Margin -89.33% -1120.1%
Net Margin -81.74% -674.9%
ROE -42.13% -845.9%
ROIC -39.63% -1336.1%
Debt/Equity 0.00 -10.5%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓FCF machine: 22.0% free cash flow margin
✓Strong 5Y sales CAGR of 13.7%

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y15.77%

5Y13.74%

3Y13.67%

TTM5.69%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-882.08%

EPS CAGR

10Y-

5Y-

3Y-

TTM-895.72%

ROCE

10Y Avg9.99%

5Y Avg-4.17%

3Y Avg-12.01%

Latest-44.1%

Peer Comparison

Drug Discovery & Development

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SLPSimulations Plus, Inc.	408.17M	20.26	-6.29	13.09%	-81.66%	-50.54%	4.27%	0.00
SDGRSchrödinger, Inc.	1.13B	17.47	-6.80	-4.21%	-68.49%	-54.77%		0.28
CERTCertara, Inc.	1.52B	9.52	-126.76	8.7%	2.62%	1.02%	5.2%	0.29

Profit & Loss

	Aug 2016	Aug 2017	Aug 2018	Aug 2019	Aug 2020	Aug 2021	Aug 2022	Aug 2023	Aug 2024	Aug 2025
Sales/Revenue+	19.97M	24.14M	29.67M	33.97M	41.59M	46.47M	53.91M	59.58M	70.01M	79.18M
Revenue Growth %	0.09%	0.21%	0.23%	0.15%	0.22%	0.12%	0.16%	0.11%	0.18%	0.13%
Cost of Goods Sold+	4.6M	6.31M	7.99M	9.03M	10.65M	10.6M	10.82M	11.63M	26.86M	32.96M
COGS % of Revenue	0.23%	0.26%	0.27%	0.27%	0.26%	0.23%	0.2%	0.2%	0.38%	0.42%
Gross Profit+	15.37M	17.83M	21.67M	24.94M	30.94M	35.87M	43.08M	47.95M	43.15M	46.22M
Gross Margin %	0.77%	0.74%	0.73%	0.73%	0.74%	0.77%	0.8%	0.8%	0.62%	0.58%
Gross Profit Growth %	0.1%	0.16%	0.22%	0.15%	0.24%	0.16%	0.2%	0.11%	-0.1%	0.07%
Operating Expenses+	8.14M	9.57M	11.37M	14.3M	19.34M	24.61M	28.17M	39.22M	37.02M	116.95M
OpEx % of Revenue	0.41%	0.4%	0.38%	0.42%	0.46%	0.53%	0.52%	0.66%	0.53%	1.48%
Selling, General & Admin	6.69M	8.2M	9.58M	11.8M	16.36M	20.57M	24.96M	34.72M	31.27M	32.84M
SG&A % of Revenue	0.34%	0.34%	0.32%	0.35%	0.39%	0.44%	0.46%	0.58%	0.45%	0.41%
Research & Development	1.45M	1.37M	1.79M	2.5M	2.98M	4.05M	3.21M	4.5M	5.75M	6.88M
R&D % of Revenue	0.07%	0.06%	0.06%	0.07%	0.07%	0.09%	0.06%	0.08%	0.08%	0.09%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	77.22M
Operating Income+	7.23M	8.26M	10.3M	10.65M	11.61M	11.25M	14.91M	8.72M	6.13M	-70.73M
Operating Margin %	0.36%	0.34%	0.35%	0.31%	0.28%	0.24%	0.28%	0.15%	0.09%	-0.89%
Operating Income Growth %	0.23%	0.14%	0.25%	0.03%	0.09%	-0.03%	0.33%	-0.41%	-0.3%	-12.54%
EBITDA+	9.16M	10.4M	13.02M	13.4M	14.57M	14.84M	18.48M	12.56M	11.8M	-62.52M
EBITDA Margin %	0.46%	0.43%	0.44%	0.39%	0.35%	0.32%	0.34%	0.21%	0.17%	-0.79%
EBITDA Growth %	0.17%	0.13%	0.25%	0.03%	0.09%	0.02%	0.25%	-0.32%	-0.06%	-6.3%
D&A (Non-Cash Add-back)	1.93M	2.14M	2.72M	2.75M	2.96M	3.59M	3.57M	3.84M	5.67M	8.21M
EBIT	7.24M	8.28M	10.3M	10.56M	11.39M	11.11M	15.12M	9.22M	6.13M	6.49M
Net Interest Income+	18.01K	-22.33K	27.12K	34K	30K	179K	717K	4.13M	4.38M	722K
Interest Income	18.01K	15.86K	27.12K	34K	30K	201K	717K	4.13M	4.38M	722K
Interest Expense	0	38.19K	0	0	0	22K	0	0	0	0
Other Income/Expense	4.59K	-24.02K	-158.85K	-92K	-218K	-168K	204K	2.97M	6.28M	1.35M
Pretax Income+	7.24M	8.24M	10.14M	10.56M	11.39M	11.09M	15.12M	11.7M	12.41M	-69.38M
Pretax Margin %	0.36%	0.34%	0.34%	0.31%	0.27%	0.24%	0.28%	0.2%	0.18%	-0.88%
Income Tax+	2.29M	2.45M	1.2M	1.97M	2.06M	1.3M	2.63M	1.73M	2.46M	-4.66M
Effective Tax Rate %	0.68%	0.7%	0.88%	0.81%	0.82%	0.88%	0.83%	0.85%	0.8%	0.93%
Net Income+	4.95M	5.79M	8.93M	8.58M	9.33M	9.78M	12.48M	9.96M	9.95M	-64.72M
Net Margin %	0.25%	0.24%	0.3%	0.25%	0.22%	0.21%	0.23%	0.17%	0.14%	-0.82%
Net Income Growth %	0.29%	0.17%	0.54%	-0.04%	0.09%	0.05%	0.28%	-0.2%	-0%	-7.5%
Net Income (Continuing)	4.95M	5.79M	8.93M	8.58M	9.33M	9.78M	12.48M	9.96M	9.95M	-64.72M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	0.29	0.33	0.50	0.48	0.50	0.47	0.60	0.49	0.49	-3.22
EPS Growth %	0.26%	0.14%	0.52%	-0.04%	0.04%	-0.06%	0.28%	-0.18%	0%	-7.57%
EPS (Basic)	0.29	0.34	0.52	0.49	0.52	0.49	0.62	0.50	0.50	-3.22
Diluted Shares Outstanding	17.21M	17.52M	17.86M	18.06M	18.54M	20.74M	20.75M	20.46M	20.3M	20.1M
Basic Shares Outstanding	17.03M	17.24M	17.33M	17.49M	17.82M	20.05M	20.2M	20.07M	19.99M	20.1M
Dividend Payout Ratio	0.69%	0.6%	0.47%	0.49%	0.46%	0.49%	0.39%	0.48%	0.48%	-

Balance Sheet

	Aug 2016	Aug 2017	Aug 2018	Aug 2019	Aug 2020	Aug 2021	Aug 2022	Aug 2023	Aug 2024	Aug 2025
Total Current Assets+	12.93M	12.67M	17.82M	21.17M	129.09M	139.31M	146.79M	130.37M	39.34M	51.55M
Cash & Short-Term Investments	8.03M	6.22M	9.4M	11.44M	116.01M	123.6M	128.24M	115.46M	20.25M	32.35M
Cash Only	8.03M	6.22M	9.4M	11.44M	49.21M	36.98M	51.57M	57.52M	10.31M	30.85M
Short-Term Investments	0	0	0	0	66.8M	86.62M	76.67M	57.94M	9.94M	1.5M
Accounts Receivable	3.7M	5.53M	7.5M	8.26M	10.52M	13.05M	13.79M	10.2M	9.14M	14.62M
Days Sales Outstanding	67.69	83.62	92.28	88.75	92.28	102.52	93.35	62.5	47.63	67.38
Inventory	784.2K	462.44K	312.59K	765.11K	969.69K	1.01M	1.39M	804K	0	0
Days Inventory Outstanding	62.2	26.76	14.27	30.94	33.24	34.85	46.92	25.23	-	-
Other Current Assets	410.81K	459.9K	610.44K	704.32K	1.6M	1.65M	3.38M	3.9M	7.75M	2.8M
Total Non-Current Assets+	15.11M	25.84M	26.33M	24.93M	40.73M	42.3M	43.71M	62.27M	168.3M	80.39M
Property, Plant & Equipment	256.38K	291.13K	335.22K	341.14K	1.36M	3.11M	2.05M	1.92M	1.84M	1.29M
Fixed Asset Turnover	77.90x	82.91x	88.50x	99.58x	30.48x	14.92x	26.27x	31.06x	38.07x	61.52x
Goodwill	4.79M	10.39M	10.39M	10.39M	12.92M	12.92M	12.92M	19.1M	96.08M	43.72M
Intangible Assets	10.03M	15.13M	14.7M	13.27M	24.99M	24.58M	26.18M	32.85M	58.84M	29.21M
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	34.08K	34.08K	37.23K	37.23K	50.97K	51K	439K	425K	542K	1.4M
Total Assets+	27.81M	38.51M	44.15M	46.09M	169.82M	181.61M	190.5M	192.64M	207.64M	131.94M
Asset Turnover	0.72x	0.63x	0.67x	0.74x	0.24x	0.26x	0.28x	0.31x	0.34x	0.60x
Asset Growth %	0.02%	0.38%	0.15%	0.04%	2.68%	0.07%	0.05%	0.01%	0.08%	-0.36%
Total Current Liabilities+	2.13M	2.04M	4.83M	4.78M	5.5M	11.57M	7.74M	11.99M	12.07M	6.72M
Accounts Payable	108.11K	240.89K	351.61K	204.07K	351K	387K	225K	144K	602K	470K
Days Payables Outstanding	8.58	13.94	16.05	8.25	12.03	13.33	7.59	4.52	8.18	5.21
Short-Term Debt	0	0	0	0	463.46K	382K	461K	442K	475K	206K
Deferred Revenue (Current)	406.52K	570.92K	766.53K	1000K	440.47K	651K	1000K	1000K	1000K	1000K
Other Current Liabilities	1.01M	1.23M	3.71M	3.4M	4.25M	10.15M	931K	3.91M	4.48M	1.34M
Current Ratio	6.08x	6.20x	3.69x	4.42x	23.45x	12.04x	18.98x	10.88x	3.26x	7.67x
Quick Ratio	5.71x	5.98x	3.63x	4.26x	23.28x	11.95x	18.80x	10.81x	3.26x	7.67x
Cash Conversion Cycle	121.31	96.44	90.5	111.44	113.49	124.04	132.68	83.21	-	-
Total Non-Current Liabilities+	2.96M	10.67M	7.4M	3.63M	8.28M	4.26M	4.52M	10.62M	13.14M	410K
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	463.31K	896K	943K	755K	531K	410K
Deferred Tax Liabilities	2.96M	4.93M	4.07M	3.63M	3.75M	3.36M	3.58M	6.54M	12.61M	0
Other Non-Current Liabilities	0	5.74M	3.33M	0	4.06M	0	0	3.33M	0	0
Total Liabilities	5.08M	12.71M	12.23M	8.41M	13.78M	15.83M	12.26M	22.61M	25.21M	7.13M
Total Debt+	0	0	0	0	926.78K	1.28M	1.4M	1.2M	1.01M	616K
Net Debt	-8.03M	-6.22M	-9.4M	-11.44M	-48.28M	-35.71M	-50.16M	-56.33M	-9.3M	-30.24M
Debt / Equity	-	-	-	-	0.01x	0.01x	0.01x	0.01x	0.01x	0.00x
Debt / EBITDA	-	-	-	-	0.06x	0.09x	0.08x	0.10x	0.09x	-
Net Debt / EBITDA	-0.88x	-0.60x	-0.72x	-0.85x	-3.31x	-2.41x	-2.71x	-4.48x	-0.79x	-
Interest Coverage	-	216.41x	-	-	-	511.50x	-	-	-	-
Total Equity+	22.73M	25.8M	31.92M	37.68M	156.04M	165.78M	178.25M	170.03M	182.43M	124.8M
Equity Growth %	0.16%	0.14%	0.24%	0.18%	3.14%	0.06%	0.08%	-0.05%	0.07%	-0.32%
Book Value per Share	1.32	1.47	1.79	2.09	8.42	7.99	8.59	8.31	8.99	6.21
Total Shareholders' Equity	22.73M	25.8M	31.92M	37.68M	156.04M	165.78M	178.25M	170.03M	182.43M	124.8M
Common Stock	7.23K	7.28K	7.42K	7.59K	9.93K	133.42M	138.51M	144.97M	20K	20K
Retained Earnings	11.35M	13.69M	18.46M	22.35M	27.44M	32.41M	40.04M	25.2M	30.35M	-34.36M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	58.47K	-43K	-308K	-141K	-251K	-271K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Aug 2016	Aug 2017	Aug 2018	Aug 2019	Aug 2020	Aug 2021	Aug 2022	Aug 2023	Aug 2024	Aug 2025
Cash from Operations+	5.42M	6.88M	9.29M	11.64M	10.91M	19.2M	17.9M	21.86M	13.32M	18.13M
Operating CF Margin %	0.27%	0.28%	0.31%	0.34%	0.26%	0.41%	0.33%	0.37%	0.19%	0.23%
Operating CF Growth %	-0.24%	0.27%	0.35%	0.25%	-0.06%	0.76%	-0.07%	0.22%	-0.39%	0.36%
Net Income	4.95M	5.79M	8.93M	8.58M	9.33M	9.78M	12.48M	9.96M	9.95M	-64.72M
Depreciation & Amortization	1.93M	2.14M	2.72M	2.75M	2.96M	3.59M	3.57M	3.84M	5.67M	8.21M
Stock-Based Compensation	347.08K	585.02K	709.08K	1.08M	1.58M	2.75M	3.04M	4.83M	6.54M	6.35M
Deferred Taxes	-23.24K	-178.37K	-1.73M	-299.1K	-377.76K	-628K	-270K	-2.1M	-1.76M	-5.43M
Other Non-Cash Items	5.63M	74.95K	152.75K	109.06K	202.03K	2.73M	1.7M	219K	-2.86M	76.29M
Working Capital Changes	-1.79M	-1.53M	-1.5M	-582.96K	-2.78M	974K	-2.62M	5.1M	-4.21M	-2.59M
Change in Receivables	-1.42M	-876.23K	-1.47M	487.97K	-2.02M	-2.43M	-3.94M	4.1M	3.13M	-581K
Change in Inventory	-495.02K	-378.99K	-339.46K	-1.31M	-247.25K	3.15M	0	0	0	0
Change in Payables	-101.3K	99.34K	110.71K	-147.53K	220.58K	39K	-162K	-81K	-477K	-132K
Cash from Investing+	-1.95M	-4.36M	-2.33M	-1.96M	-75.51M	-26.74M	4.3M	7.37M	-53.97M	3.56M
Capital Expenditures	-1.23M	-1.56M	-2.33M	-1.96M	-2.58M	-4.58M	-3.97M	-4.27M	-566K	-713K
CapEx % of Revenue	0.06%	0.06%	0.08%	0.06%	0.06%	0.1%	0.07%	0.07%	0.01%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-1.2M	-1.38M	-2.15M	0	-2.35M	-2.95M	-3.15M	0	-3.73M	-4.24M
Cash from Financing+	-3.98M	-4.34M	-3.77M	-7.65M	102.37M	-4.68M	-7.62M	-23.27M	-6.57M	-1.15M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-3.41M	-3.45M	-4.16M	-4.2M	-4.25M	-4.81M	-4.85M	-4.81M	-4.8M	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-567.95K	-888.6K	388.25K	-3.45M	-1.13M	-1.33M	-3.67M	1.54M	-2.5M	-1.58M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	4.18M	5.32M	6.96M	9.68M	8.33M	14.63M	13.93M	17.58M	12.75M	17.41M
FCF Margin %	0.21%	0.22%	0.23%	0.29%	0.2%	0.31%	0.26%	0.3%	0.18%	0.22%
FCF Growth %	-0.29%	0.27%	0.31%	0.39%	-0.14%	0.76%	-0.05%	0.26%	-0.27%	0.37%
FCF per Share	0.24	0.30	0.39	0.54	0.45	0.71	0.67	0.86	0.63	0.87
FCF Conversion (FCF/Net Income)	1.09x	1.19x	1.04x	1.36x	1.17x	1.96x	1.43x	2.19x	1.34x	-0.28x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	2.91M	2.69M	2.71M	2.67M	2.35M	1.86M	3.23M	3.2M	5.69M	1.16M

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	23.42%	23.85%	30.96%	24.66%	9.63%	6.08%	7.26%	5.72%	5.65%	-42.13%
Return on Invested Capital (ROIC)	42.24%	36.15%	36.68%	32.75%	12.99%	7.1%	8.66%	5.41%	3.21%	-39.63%
Gross Margin	76.96%	73.87%	73.05%	73.43%	74.39%	77.19%	79.92%	80.48%	61.63%	58.38%
Net Margin	24.79%	23.98%	30.12%	25.27%	22.44%	21.05%	23.16%	16.72%	14.22%	-81.74%
Debt / Equity	-	-	-	-	0.01x	0.01x	0.01x	0.01x	0.01x	0.00x
Interest Coverage	-	216.41x	-	-	-	511.50x	-	-	-	-
FCF Conversion	1.09x	1.19x	1.04x	1.36x	1.17x	1.96x	1.43x	2.19x	1.34x	-0.28x
Revenue Growth	9.05%	20.86%	22.9%	14.51%	22.43%	11.73%	16.01%	10.52%	17.52%	13.09%

Revenue by Segment

	2014	2018	2019	2020	2021	2022	2023	2024	2025
License and Maintenance	-	-	-	-	-	-	-	41.02M	45.83M
License and Maintenance Growth	-	-	-	-	-	-	-	-	11.71%
Service	-	-	-	-	18.8M	-	-	28.99M	33.35M
Service Growth	-	-	-	-	-	-	-	-	15.05%
Software	-	-	-	-	27.67M	32.64M	36.52M	-	-
Software Growth	-	-	-	-	-	17.97%	11.87%	-	-
Services	-	-	-	-	-	21.26M	23.06M	-	-
Services Growth	-	-	-	-	-	-	8.45%	-	-
Operatings	-	-	-	41.59M	-	-	-	-	-
Operatings Growth	-	-	-	-	-	-	-	-	-
Simulations Plus, Inc.	-	30K	54K	21.96M	-	-	-	-	-
Simulations Plus, Inc. Growth	-	-	80.00%	40568.52%	-	-	-	-	-
Cognigen	-	-	-	11.11M	-	-	-	-	-
Cognigen Growth	-	-	-	-	-	-	-	-	-
D I L Isym	-	-	-	6.95M	-	-	-	-	-
D I L Isym Growth	-	-	-	-	-	-	-	-	-
Lixoft	-	-	-	1.57M	-	-	-	-	-
Lixoft Growth	-	-	-	-	-	-	-	-	-
DILIsym	-	3.16M	-	-	-	-	-	-	-
DILIsym Growth	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2014	2018	2019	2020	2021	2022	2023	2024	2025
North And South America	-	-	-	29.67M	32.55M	37.68M	40.82M	50.47M	57.7M
North And South America Growth	-	-	-	-	9.69%	15.77%	8.32%	23.66%	14.32%
Europe	2.98M	-	-	-	-	-	-	-	14.19M
Europe Growth	-	-	-	-	-	-	-	-	-
Asia	2.82M	-	-	6.09M	6.01M	5.84M	7.05M	5.47M	7.29M
Asia Growth	-	-	-	-	-1.26%	-2.89%	20.73%	-22.41%	33.25%
EMEA	-	-	-	5.83M	7.91M	10.39M	11.71M	14.07M	-
EMEA Growth	-	-	-	-	35.68%	31.39%	12.76%	20.14%	-
North America	5.63M	-	-	-	-	-	-	-	-
North America Growth	-	-	-	-	-	-	-	-	-
South America	26K	-	-	-	-	-	-	-	-
South America Growth	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Simulations Plus, Inc. (SLP) reported $78.7M in revenue for fiscal year 2025. This represents a 733% increase from $9.4M in 2012.

Simulations Plus, Inc. (SLP) grew revenue by 13.1% over the past year. This is steady growth.

Simulations Plus, Inc. (SLP) reported a net loss of $64.2M for fiscal year 2025.

Dividend & Returns

Simulations Plus, Inc. (SLP) has a return on equity (ROE) of -42.1%. Negative ROE indicates the company is unprofitable.

Simulations Plus, Inc. (SLP) generated $23.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.